estudio patológico bloque 9

7/21/2019 Estudio Patolgico Bloque 9

1/19

ESTUDIO PATOLGICO BLOQUE 9

CRISTIAN SERNA ARBELEZ

20121079012KEVIN MANUEL RUNZA

2012179008

KAREN SNCHEZ20121079068

UNIVERSIDAD DISTRITAL RANCISCO !OS" DE CALDAS

ACULTAD TECNOLGICATECNOLOG#A EN CONSTRUCCIONES CIVILESPATOLOG#A DEL CONCRETO

BOGOT201$

1


2/19

ESTUDIO PATOLGICO% BLOQUE 9

CRISTIAN SERNA ARBELEZ20121079012

KEVIN MANUEL RUNZA

20121079008KAREN SNCHEZ

20121079068

P&'()*+' ,-./ ) / /-3./+4&/ 5/+''3/ ) *'.*&)+'

D-&-3-' 5'&%I.3 M-+'. )./

'*).+) / */&3' ) / /-3./+4&/ 5/+''3/ ) *'.*&)+'

UNIVERSIDAD DISTRITAL RANCISCO !OS" DE CALDASACULTAD TECNOLGICA

TECNOLOG#A EN CONSTRUCCIONES CIVILESPATOLOG#A DEL CONCRETO

BOGOT201$

2


3/19

CONTENIDO

GLOSARIO...........................................................................................................7

INTRODUCCIN...................................................................................................8

OBJETIVOS..........................................................................................................9

ALCANCES Y LIMITACIONES...............................................................................10

JUSTIFICACIN..................................................................................................11

METODOLOGA..................................................................................................12

INVESTIGACIN PRELIMINAR.............................................................................13

VULNERABILIDAD...............................................................................................18

3


4/19

LISTA DE TABLAS

Tabla 1.

4


5/19

LISTA DE GRAICAS

5


6/19

LISTA DE ANEOS

Anex A. Re!"#$% &$!%'&"()))))))))))))))))))))))*

Anex B. Plan# A%+,"$e($-n"(#))))))))))))))))))))......*

Anex C. Plan# E#$%,($,%ale#)))))))))))))))))))))......*

Anex C. Plan# e le/an$a0"en$ e a#...))))))))))))))......*

Anex C. Plan# e %e2ab"l"$a("-n..)))))))))))))))))))......*

6


7/19

GLOSARIO

BIORECEPTIVIDAD3 42a(e %e&e%en("a a $a# a+,ella# 5%5"eae# el (n(%e$6(0 la# e (,al+,"e% $% 0a$e%"al +,e (n$%"b,7en &a/%e(en a la (ln"8a("-n6e#$able("0"en$ 7 e#a%%ll e 0"(%%!an"#0# e %"!en an"0al /e!e$al +,ea&e($an la ,%ab"l"a (0 0a$e%"al e (n#$%,(("-n.91

BLO:UE ;3 e"&"(" e la Un"/e%#"a "#$%"$al F%an("#( J#< e Cala# &a(,l$a$e(nl-!"(a6 #"$" ne $"ene l,!a%


8/19

INTRODUCCIN

El #"!,"en$e (,0en$ 5%e#en$a ,n e#$," e 5a$l!=a6 /,lne%ab"l"a 7%e2ab"l"$a("-n %eal"8a en la &a(,l$a $e(nl-!"(a e la ,n"/e%#"a D"#$%"$alF%an("#( J#< e Cala# al bl+,e e a,la# "en$"&"(a (0 4bl+,e ;9 e#$ee#$," #e %eal"8a en$% el 0a%( e la a#"!na$,%a 45a$l!=a el (n(%e$9"05a%$"a 5% el "n!en"e% M"l$n Mena a l la%! el #e!,n #e0e#$%e el a>1 en la ,n"/e%#"a an$e# 0en("naa6 ba? n"n!n (n(e5$ 5,ee $0a%#ee#$e (,0en$ (0 ,n "a!n#$"( %eal e la (n"("-n el e"&"(" n" 0,(20en# $0a%#e (0 %eale# la# 5%5,e#$a# e %e2ab"l"$a("-n a+,= ex5,e#$a#6 5,e##" b"en #e (n&=a en la (al"a e 1 4NSR19.

El #"!,"en$e (,0en$ 5%e#en$a ,n e#$," e 5a$l-!"( a l# ele0en$# $an$e#$%,($,%ale# (0 n e#$%,($,%ale# el #,?e$6 e la 0"#0a &%0a 5%e#en$aal$e%na$"/a# 5a%a la #l,("-n e la# (a,#a# e e#$a# 5a$l!=a# 76 ,n e#$," e/,lne%ab"l"a #=#0"(a (n 0"%a# a e$e%0"na% #" e# n ne(e#a%" el%e&%8a0"en$ e#$%,($,%al el 0"#0.

8


9/19

OB!ETIVOS

O:;)+-


10/19

ALCANCES = LIMITACIONES

E#$e e#$," #e l"0"$a a ,n e?e%("(" a(a


11/19

!USTIICACIN

E#$e e#$," #"%/e a +,"ene# l %eal"8an (0 a5l"(a("-n e l# (n("0"en$# 70


12/19

METODOLOG#A

A l la%! el 5%7e($ #e #"!,"- la #"!,"en$e 0e$l!=a6


13/19

S(())i0*!(

#a)i(*$(

6u*(rabii!a! +i+.i)a

Ori(*$a)i0* Eab%ra)i0*!( .%!(%

7*!i)( !(1(8ibii!a

!

,()%*%)i.i(*$%!( #a)i(*$(

i*+#())i0* 6i+ua

,(&i+$r%9%$%&ra/)

%

:i+$a!%

!((+i%*(+

Eab%ra)i0* !( #a*%!( (6a*$a.i(*$% !(

!a5%+

Dia&*%+$i)%#r(i.i*ar

I*6(+$i&a)i0*

Eab%ra)i0*

!( #a*%+

,()%())i0* !(i*9%r.a)i0* #r(6ia

Ori(*$a)i0*

Eab%ra)i0* !(

!%)u.(*$%

Mar)%$(%ri)%

Eab%ra)i0* !(!%)u.(*$%

E#+,e0a 13 0e$l!=a

INVESTIGACIN PRELIMINAR

11D)*&-5*->. 3).)&/ ) 5/*-).+)%

13


14/19

La e"&"(a("-n #e en(,en$%a ,b"(aa en la T%an#/e%#al B N H HK S,% e la(",a e B!$' en la See Te(nl-!"(a e la Un"/e%#"a D"#$%"$al F%an("#(J#< e Cala# #e en(,en$%a &,n("nan (0 ,n (n?,n$ e a,la# e (la#e#e#e 1;;.

I0a!en 13 ,b"(a("-n e la &a(,l$a $e(nl-!"(a $0aa el #"$" e la e05%ee$%n"a e la ,n"/e%#"a "#$%"$al32$$53(0,n"a.,"#$%"$al.e,.(e05%ene$%n"a&e(2a#"05%$an$e#

El #"#$e0a e#$%,($,%al +,e #e le a#("a al bl+,e e a,la# (n(" (0 4bl+,e;96 el (,al e# el #,?e$ e "n$e%1 4NSR 19 en el (a5=$,l

A.H.>.1.9T"5# e #"#$e0a# e#$%,($,%ale#9.

En $


15/19

(en$=0e$%#6 la# ln!"$,e# e l# ele0en$# e#$%,($,%ale# #n /a%"able# e 0+,e e#$a# #e e$alla%an en l# 5lan# el bl+,e anex# al &"nal el (,0en$#,# 0,%# "/"#%"# 7 5e%"0e$%ale# #e en(,en$%an (n&%0a# 5% 0,%# ela%"ll# $le$e "n#$ala# en #!a 7 ,n"# (n 0%$e% e (e0en$ 2"%',l"( la

(,b"e%$a e la e"&"(a("-n e#$' (n&%0aa 5% ,n #"#$e0a e (e%(2a# 7 /"!a# ea0a%%e ne e#(an#an $e?a# e &"b%(e0en$6 la "#5#"("-n e e#$e #"#$e0a(n&%0a # (,b"e%$a# a # a!,a# ne (aa ,na (,b%e $%e# #alne# e?an,n 5a#"ll e#(,b"e%$ en (,an$ a a(aba# l# n"(# ele0en$# 5ae$a#en$% e la e"&"(a("-n #n l# ele0en$# e#$%,($,%ale#6 la# 5a%ee# 5e%"0e$%ale##e en(,en$%an en la%"ll a la /"#$a #"n n"n!n $"5 e %e(,b%"0"en$ 7 l# 0,%#"/"#%"# #e en(,en$%an en la%"ll a la /"#$a ne el la%"ll e#$a la(a6 ela(aba e 5"## 5a%a $a la e"&"(a("-n (n#"#$e en $able$a# e !%an"$ ne!% 7!%"# (n &n blan( e HH (en$=0e$%# la e"&"(a("-n (,en$a (n ,n '%ea(n#$%,"a e HK.Q;0> 5a%a la 5%"0e%a 5lan$a6 H;.0> 5a%a la #e!,na 5lan$a6

(n ,n $$al e ;.;H0> (0 '%ea $$al (n#$%,"a.

12I.5)**->.


16/19

Tabla 13 &%0a$ e "n&%0a("-n 5%e/"a I

16


17/19

Tabla >3 &"(2a e "n&%0a("-n 5%e/"a II

17


18/19

Tabla H3 &"(2a e "n&%0a("-n 5%e/"a III

18


19/19

VULNERABILIDAD

En el e#$," e la /,lne%ab"l"a e la e"&"(a("-n6 #e e05le- el 0H.K /e(e# la %"!"e8 e ,na n,e/a e"&"(a("-n(n#$%,"a ba? l# %e+,"#"$# e la NSR1.

19

estudio patológico bloque 9

Documents